Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury
Figure 2
Bronchoalveolar levels of coagulation and fibrinolysis. Thrombin-antithrombin (TATc), soluble tissue factor (TF), factor VIIa (FVIIa), plasminogen activator activity (PAA) and plasminogen activator inhibitor type 1 (PAI-1) in patients who developed VALI (closed symbols, ), and patients who did not develop VALI (open symbols, ). Data are medians ± IQR. *.
